The median OS was 28 months with abiraterone-prednisone, 37 months with olaparib alone, and 68 months with abiraterone-prednisone-olaparib. In patients with metastatic castration-resistant prostate ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

One in four Breast Cancer patients in India carry inherited genetic risk variants linked to cancer risk, according to a study conducted by the IIT-Madras and Karikinos Healthcare.

The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across ...

Scientists have developed Evo 2, a powerful AI model that can analyze and generate DNA sequences across all domains of life.

Jacob Johnson learned that he was a carrier for the BRCA2 gene in 2013 after testing was recommended due to a strong history ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

Chennai: One in four Indian breast cancer patients carries inherited genetic variants that raise cancer risk beyond the commonly tested BRCA1 and BRCA.

Overall, the findings suggest that a shift away from one-size-fits-all mammography toward personalized screening schedules could save more lives with less collateral harm by screening more ...

The DNA foundation model Evo 2, first released in February 2025 as a preprint, is now published in the journal Nature.

An artificial intelligence (AI) algorithm used to detect breast cancer in screening scans has been adapted into a risk score that estimates a woman's risk of developing breast cancer over the next ...